Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Enterprise Products Partners

Dividend champions are a great source of ideas for investors seeking either high yield or dividend growth. In this article, I conduct a quarterly examination of the dividend champions to identify two stocks that may be suitable for high-yield investors.

2 Dividend Champions For High-Yield Income Generation

Philip Morris

Earnings season is upon us. At a time when many companies are expecting to confirm evidence of an earnings recession, investors are looking for any bright spots.

Analyst Sentiment May Be The Boost Altria Stock Needs - Altria Group (NYSE:MO), Philip Morris Intl (NYSE:PM)

B&G Foods

Altria makes cigarettes, a cash cow business that has supported dividend growth for years. B&G Foods makes branded food products, but it recently cut its dividend.

Better Buy: B&G Foods vs. Altria

Costco

Costco's simple formula for success makes it an evergreen stock. Altria faces an existential crisis as tobacco sales continue to decline.

Better Buy: Costco vs. Altria

Mastercard

In today's article, I will introduce you to my two top dividend picks of the month, which I currently consider attractive due to various factors. Both companies have strong financial health, possess important competitive advantages and their valuation is currently attractive.

If I Could Only Buy 2 Dividend Stocks In April 2023

AT&T

Blue-chip stocks are known and admired for their consistency. Like their eponymous poker chips, these companies provide dependable revenue and earnings.

3 Blue-Chip Stocks to Buy at an All-Time Low in April

Analyst Sentiment May be the Boost Altria Stock Needs

British American Tobacco

Altria Group and British American Tobacco both boast strong brand portfolios. Both companies should consistently grow over the long haul.

Got $1,000? 2 Ultra-High-Yield Dividend Stocks to Get Your Hands On

West Virginia has settled a lawsuit with e-cigarette maker Juul Labs for a total of $7.9 million, the state's attorney general announced Monday.

Juul settles lawsuit with West Virginia for $7.9 million

Dow Inc

Energy Transfer LP Unit

Diamondback Energy

Prudential Financial

Verizon

Walgreens

When only eight stocks accounted for the majority of the gains in the S&P 500 for the first quarter, there must be some incredible value lurking for investors, especially as we now head towards the “sell in May and go away” time of the year.

Dividend Lovers Load Up on 7 Surprising Value Blue Chips With Huge Yields

Abbott Labs

Gorman-Rupp

Leggett & Platt

Lowe's

MSA Safety

Nordson

S&P Global

Stanley Black & Decker

Sysco

Tennant

The 49 Dividend Kings collectively lost 1 basis point in March but retained a positive year-to-date return. The 12 best dividend kings selected for March, based on forecasted growth and valuation, underperformed the average dividend king return by 32 bps.

My 12 Best Dividend Kings For April 2023

Apple

Automatic Data Processing

Ameriprise Financial

Best Buy

Blackstone Group

Comcast

CME Group

CVS Health

Fidelity National Information

Global Payments

Home Depot

Intel

Johnson & Johnson

Nexstar Media Group

Realty Income Corp

PepsiCo

Schwab US Dividend Equity ETF

Charles Schwab

Toronto-Dominion Bank

Tractor Supply

The portfolio remains at record high levels of cash holdings, which is fine for the first time in a long time, cash is providing a decent return. Income growth is projected at 7.9% for the year, up from last month. This was primarily due to including an estimated return on cash.

My Dividend Growth Portfolio March Update: Still Accumulating Cash

Kimberly-Clark

Investing in dividend stocks is vital to many long-term investors. Dividends are a discretionary distribution of profits paid to investors, usually by publicly-traded companies.

The 3 Best Dividend Stocks to Buy for April

AbbVie

AmerisourceBergen

Cigna

ConocoPhillips

Cisco Systems

Dell Technologies

Devon Energy

eBay

Expeditors International of Washington

Twenty-First Century Fox

Gilead Sciences

KLA-Tencor

Lam Research

McKesson

Mosaic

Marathon Petroleum

Nutrien

Nucor

QUALCOMM

The following is a dividend portfolio strategy for large caps that score the highest amongst Joel Greenblatt's Magic Formula screener. The list follows large caps that have dividends.

Magic Formula Dividend Portfolio For April

Dividends reward investors for their patience. Bear markets are a good time to get more value from dividend stocks with higher yields.

Sleep Well at Night Knowing You Have These Kinds of Stocks in Your Portfolio

Franklin Resources

Boston Properties

Federal Realty Investment Trust

If you invest in dividend stocks, you are probably looking for long-term growth to go with the income. Otherwise you might be content to hold one-month U.S. Treasury bills, which yield 4.5% or park your money in an online savings account for a yield close to 4%.

14 dividend stocks yielding 4% or more that are expected to increase payouts in 2023 and 2024

News for Altria Stock (MO)